Publications
- Dominance of EGFR and insignificant KRAS mutations in prediction of Tyrosin-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status2009 | Central Library of Charles University
- Impact of EGFR and KRAS mutations on survival prognosis of NSCLC patients treated with tyrosine-kinase inhibitors: Comparison of gefitinib and erlotinib.2009 | Central Library of Charles University
- NUT midline pulmonary carcinoma - molecular profiling of three cases and a literature review of the per-spectives for precision oncology2023 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Lung adenocarcinoma with a rare EGFR mutation and infrequent resistance to treatment2022 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Systemic lupus erythematosus and secondary antiphospholipid syndrome in native sisters with reduced fertility2022 | Faculty of Medicine in Pilsen
- The Use of CT Pattern in Differentiating Non-invasive, Minimally Invasive and Invasive Variants of Lung Adenocarcinoma2021 | Faculty of Medicine in Pilsen
- Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report2020 | Faculty of Medicine in Pilsen
- When not even four ALK inhibitors are enough2020 | Faculty of Medicine in Pilsen
- Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib2020 | Faculty of Medicine in Pilsen
- Echinococcus multilocularis: Diagnostic problem in a liver core biopsy2020 | Faculty of Medicine in Pilsen
Loading network view...